The parasite appears to make infected wolves less risk-averse, potentially influencing the behavior of packs.

The international group coordinating emergency vaccines recommends administering one dose instead of two to combat the “dire shortage” of cholera vaccines worldwide.

The outbreak of the Sudan strain of ebolavirus, which includes eight other suspected cases, is the first to hit Uganda in more than a decade.

Of the pathogens known to have infected humans, more than half may cause more widespread disease as a result of rising temperatures, precipitation changes, or other climate-related factors, a study finds.

Research traces the evolution of a gene variant that reduces the risk of Alzheimer’s disease, finding that it originally evolved in response to infectious bacteria.

Genetic variants that reduce the editing levels of double-stranded RNA are associated with autoimmune and immune-mediated conditions, a study finds.

Thirteen people with the illness have tested negative for Ebola and Marburg. The Tanzanian government continues to investigate the source.

Multiple lines of evidence contradict the idea that the disease came to Europe via trans-Atlantic exchange.

The biotech company Verve Therapeutics launched the study with the aim of using base editing to treat a genetic condition that causes high cholesterol and increases a person's risk of developing cardiovascular disease.

Putting on a mask to protect oneself and others against disease is nothing new, nor is resistance to mask-wearing, but mask designs have changed considerably from their first iterations.

A technique for quantifying tumor mRNA production from messy tissue sample data uncovers an unexpected correlation between it and disease stage in 15 cancer types.

An interesting but preliminary biomarker study’s reception illustrates the challenges of conducting and communicating nuanced research in the era of social media.

Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.